CMS on Thursday (July 30) released a request for information on whether the agency should grant Part D providers exceptions to electronic prescribing requirements for controlled substances and under what circumstances. The RFI follows the 2018 SUPPORT for Patients and Communities Act, which requires Medicare Part D and Medicare Advantage prescription drug plans to electronically prescribe controlled substances in accordance with an electronic prescription drug program beginning on Jan. 1, 2021. The RFI asks for stakeholder feedback on how CMS...